The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected Patients
Abstract
Purpose: To determine incidence of non–AIDS-defining cancers (NADC) in HIV–infected patients before (P1) and during (P2) the use of highly active antiretroviral therapy (HAART) relative to that observed in the French general population (FGP) of the same age and sex. Patients and Methods: Sex- and age-adjusted NADC standardized incidence ratios (SIR), with FGP as reference, were estimated in 1992 to 1995 (P1) and in 1996 to 1999 (P2) in a French Hospital Database on HIV prospective hospital cohort study. Results: NADCs were diagnosed in 260 patients during P1 and 391 patients during P2 among the 77,025 patients included in the database between January 1, 1992, and December 31, 1999. Estimated incidence of all cancers was higher in HIV-infected men than in FGP during both periods (P1 SIR = 2.36 and P2 SIR = 1.91). No excess of cancers was observed among HIV-infected women in either period. Incidence of all cancers did not change from P1 to P2 in either sex (SIR = 0.96 for men and 1.00 for women). In contrast, incidence of Hodgkin’s disease (HD) was higher than in FGP in both sexes and both periods and increased in P2 as compared with P1; incidence of lung cancer was higher in both sexes during P2. Conclusion: Relative to FGP, the overall incidence of NADCs was increased in HIV-infected men but not in women and did not differ between P1 and P2. Only HD was much more common in HIV infection, and the potential role of HAART on HD cannot be excluded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Solid Cancers after Bone Marrow Transplantation
Curtis, R. E., Rowlings, P. A., Deeg, H. J., Shriner, D. A., Socié, G., Travis, L. B., Horowitz, M. M., Witherspoon, R. P., Hoover, R. N., Sobocinski, K. A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361301 · Cited by 965
Frisch, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1500 · Cited by 885
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch, M. (2001) · JAMA · doi:10.1001/jama.285.13.1736 · Cited by 821
Spectrum of AIDS-associated malignant disorders
Goedert, J. J., Coté, T. R., Virgo, P., Scoppa, S. M., Kingma, D. W., Gail, M. H., Jaffe, E. S., & Biggar, R. J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09028-4 · Cited by 701
International Collaboration on HIV and Cancer (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1823 · Cited by 647
Saves, M., Chene, G., Ducimetiere, P., Leport, C., Le Moal, G., Amouyel, P., Arveiler, D., Ruidavets, J.-B., Reynes, J., Bingham, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375844 · Cited by 400
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Besson, C., Goubar, A., Gabarre, J., Rozenbaum, W., Pialoux, G., Châtelet, F.-P., Katlama, C., Charlotte, F., Dupont, B., Brousse, N., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2339 · Cited by 378
Self-citationRates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis
Grulich, A. E., Li, Y., McDonald, A., Correll, P. K. L., Law, M. G., & Kaldor, J. M. (2002) · AIDS · doi:10.1097/00002030-200205240-00009 · Cited by 245
Immune Deficiency and Risk for Malignancy Among Persons with AIDS
Mbulaiteye, S. M., Biggar, R. J., Goedert, J. J., & Engels, E. A. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200304150-00010 · Cited by 233
Cited by
Clifford, G. M., Polesel, J., Rickenbach, M., Study, O. B. O. T. S. H. C., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji072 · Cited by 863
Trends in cancer risk among people with AIDS in the United States 1980–2002
Engels, E. A., Pfeiffer, R. M., Goedert, J. J., Virgo, P., McNeel, T. S., Scoppa, S. M., & Biggar, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000238411.75324.59 · Cited by 775
Cancer risk in people infected with human immunodeficiency virus in the United States
Engels, E. A., Biggar, R. J., Hall, H. I., Cross, H., Crutchfield, A., Finch, J. L., Grigg, R., Hylton, T., Pawlish, K. S., McNeel, T. S., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23487 · Cited by 768
Alberg, A. J., Brock, M. V., Ford, J. G., Samet, J. M., & Spivack, S. D. (2013) · Chest · doi:10.1378/chest.12-2345 · Cited by 737
Guiguet, M., Boué, F., Cadranel, J., Lang, J.-M., Rosenthal, E., & Costagliola, D. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70282-7 · Cited by 571
Self-citationA Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals
Shiels, M. S., Cole, S. R., Kirk, G. D., & Poole, C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b327ca · Cited by 516
Projected life expectancy of people with HIV according to timing of diagnosis
Nakagawa, F., Lodwick, R. K., Smith, C. J., Smith, R., Cambiano, V., Lundgren, J. D., Delpech, V., & Phillips, A. N. (2012) · AIDS · doi:10.1097/qad.0b013e32834dcec9 · Cited by 443
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Biggar, R. J., Jaffe, E. S., Goedert, J. J., Chaturvedi, A., Pfeiffer, R., Engels, E. A., & Study, F. T. H. C. M. (2006) · Blood · doi:10.1182/blood-2006-05-024109 · Cited by 436
HIV Infection Is Associated with an Increased Risk for Lung Cancer, Independent of Smoking
Kirk, G. D., Merlo, C., O'Driscoll, P., Mehta, S. H., Galai, N., Vlahov, D., Samet, J., & Engels, E. A. (2007) · Clinical Infectious Diseases · doi:10.1086/518606 · Cited by 387
Life expectancy living with HIV: recent estimates and future implications
Nakagawa, F., May, M., & Phillips, A. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32835ba6b1 · Cited by 373
Lewden, C. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh307 · Cited by 373
Powles, T., Robinson, D., Stebbing, J., Shamash, J., Nelson, M., Gazzard, B., Mandelia, S., Møller, H., & Bower, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6626 · Cited by 360
AIDS-Related Cancer and Severity of Immunosuppression in Persons With AIDS
Biggar, R. J., Chaturvedi, A. K., Goedert, J. J., Engels, E. A., & Study, F. T. H. C. M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm010 · Cited by 353
Cancer, Physical Activity, and Exercise
Brown, J. C., Winters‐Stone, K., Lee, A., & Schmitz, K. H. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c120005 · Cited by 346
Lewden, C., May, T., Rosenthal, E., Burty, C., Bonnet, F., Costagliola, D., Jougla, E., Semaille, C., Morlat, P., Salmon, D., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817efb54 · Cited by 342
Self-citationCrum-Cianflone, N., Hullsiek, K. H., Marconi, V., Weintrob, A., Ganesan, A., Barthel, R. V., Fraser, S., Agan, B. K., & Wegner, S. (2009) · AIDS · doi:10.1097/qad.0b013e328317cc2d · Cited by 278
Elevated Incidence of Lung Cancer Among HIV-Infected Individuals
Engels, E. A., Brock, M. V., Chen, J., Hooker, C. M., Gillison, M., & Moore, R. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4413 · Cited by 261
Cobucci, R. N. O., Lima, P. H., de Souza, P. C., Costa, V. V., Cornetta, M. D. C. D. M., Fernandes, J. V., & Gonçalves, A. K. (2015) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2014.08.003 · Cited by 175
Metadata
- Authors
- Herida, M., Mary-Krause, M., Kaphan, R., Cadranel, J., Poizot-Martin, I., Rabaud, C., Plaisance, N., Tissot-Dupont, H., Boue, F., Lang, J.-M., & Costagliola, D.
- Venue
- Journal of Clinical Oncology
- Published
- 2003-09-15
- Volume
- 21
- Issue
- 18
- Pages
- 3447-3453
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2117495256
- Cited by
- 339
- References
- 22
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.